These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 22724878)

  • 1. Sampling error in histopathology findings of nonalcoholic fatty liver disease: a post mortem liver histology study.
    Merat S; Sotoudehmanesh R; Nouraie M; Peikan-Heirati M; Sepanlou SG; Malekzadeh R; Sotoudeh M
    Arch Iran Med; 2012 Jul; 15(7):418-21. PubMed ID: 22724878
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation of paired liver biopsies in morbidly obese patients with suspected nonalcoholic fatty liver disease.
    Merriman RB; Ferrell LD; Patti MG; Weston SR; Pabst MS; Aouizerat BE; Bass NM
    Hepatology; 2006 Oct; 44(4):874-80. PubMed ID: 17006934
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A modification of the Brunt system for scoring liver histology of patients with non-alcoholic fatty liver disease.
    Merat S; Khadem-Sameni F; Nouraie M; Derakhshan MH; Tavangar SM; Mossaffa S; Malekzadeh R; Sotoudeh M
    Arch Iran Med; 2010 Jan; 13(1):38-44. PubMed ID: 20039768
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Histopathology of pediatric nonalcoholic fatty liver disease.
    Schwimmer JB; Behling C; Newbury R; Deutsch R; Nievergelt C; Schork NJ; Lavine JE
    Hepatology; 2005 Sep; 42(3):641-9. PubMed ID: 16116629
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatic histopathology of morbid obesity: concurrence of other forms of chronic liver disease.
    Liew PL; Lee WJ; Lee YC; Wang HH; Wang W; Lin YC
    Obes Surg; 2006 Dec; 16(12):1584-93. PubMed ID: 17217634
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Histopathologic variability between the right and left lobes of the liver in morbidly obese patients undergoing Roux-en-Y bypass.
    Larson SP; Bowers SP; Palekar NA; Ward JA; Pulcini JP; Harrison SA
    Clin Gastroenterol Hepatol; 2007 Nov; 5(11):1329-32. PubMed ID: 17702661
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Steatohepatitic hepatocellular carcinoma (SH-HCC): a distinctive histological variant of HCC in hepatitis C virus-related cirrhosis with associated NAFLD/NASH.
    Salomao M; Yu WM; Brown RS; Emond JC; Lefkowitch JH
    Am J Surg Pathol; 2010 Nov; 34(11):1630-6. PubMed ID: 20975341
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sampling variability of liver biopsy in nonalcoholic fatty liver disease.
    Ratziu V; Charlotte F; Heurtier A; Gombert S; Giral P; Bruckert E; Grimaldi A; Capron F; Poynard T;
    Gastroenterology; 2005 Jun; 128(7):1898-906. PubMed ID: 15940625
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development and validation of a new histological score for pediatric non-alcoholic fatty liver disease.
    Alkhouri N; De Vito R; Alisi A; Yerian L; Lopez R; Feldstein AE; Nobili V
    J Hepatol; 2012 Dec; 57(6):1312-8. PubMed ID: 22871498
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of interventions on intra- and interobserver agreement on interpretation of nonalcoholic fatty liver disease histology.
    Gawrieh S; Knoedler DM; Saeian K; Wallace JR; Komorowski RA
    Ann Diagn Pathol; 2011 Feb; 15(1):19-24. PubMed ID: 21106424
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum fragmented cytokeratin 18 levels reflect the histologic activity score of nonalcoholic fatty liver disease more accurately than serum alanine aminotransferase levels.
    Tsutsui M; Tanaka N; Kawakubo M; Sheena Y; Horiuchi A; Komatsu M; Nagaya T; Joshita S; Umemura T; Ichijo T; Matsumoto A; Yoshizawa K; Aoyama T; Tanaka E; Sano K
    J Clin Gastroenterol; 2010 Jul; 44(6):440-7. PubMed ID: 20104187
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design and validation of a histological scoring system for nonalcoholic fatty liver disease.
    Kleiner DE; Brunt EM; Van Natta M; Behling C; Contos MJ; Cummings OW; Ferrell LD; Liu YC; Torbenson MS; Unalp-Arida A; Yeh M; McCullough AJ; Sanyal AJ;
    Hepatology; 2005 Jun; 41(6):1313-21. PubMed ID: 15915461
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nonalcoholic fatty liver disease: assessment of variability in pathologic interpretations.
    Younossi ZM; Gramlich T; Liu YC; Matteoni C; Petrelli M; Goldblum J; Rybicki L; McCullough AJ
    Mod Pathol; 1998 Jun; 11(6):560-5. PubMed ID: 9647594
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Portal chronic inflammation in nonalcoholic fatty liver disease (NAFLD): a histologic marker of advanced NAFLD-Clinicopathologic correlations from the nonalcoholic steatohepatitis clinical research network.
    Brunt EM; Kleiner DE; Wilson LA; Unalp A; Behling CE; Lavine JE; Neuschwander-Tetri BA;
    Hepatology; 2009 Mar; 49(3):809-20. PubMed ID: 19142989
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Weight loss and non-alcoholic fatty liver disease: falls in gamma-glutamyl transferase concentrations are associated with histologic improvement.
    Dixon JB; Bhathal PS; O'Brien PE
    Obes Surg; 2006 Oct; 16(10):1278-86. PubMed ID: 17059735
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Relationship between the severity of liver damage and the serum leptin level for nonalcoholic fatty liver disease].
    Kim KO; Park SH; Park CH; Han TH; Yoo KS; Kim JH; Lee MS; Kim DJ; Park CK; Cho HD
    Korean J Hepatol; 2005 Mar; 11(1):51-8. PubMed ID: 15788885
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Portal fibrosis and hepatic steatosis in morbidly obese subjects: A spectrum of nonalcoholic fatty liver disease.
    Abrams GA; Kunde SS; Lazenby AJ; Clements RH
    Hepatology; 2004 Aug; 40(2):475-83. PubMed ID: 15368453
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-alcoholic steatohepatitis in children.
    Nanda K
    Pediatr Transplant; 2004 Dec; 8(6):613-8. PubMed ID: 15598336
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Validation of the non-alcoholic fatty liver disease activity score.
    Hjelkrem M; Stauch C; Shaw J; Harrison SA
    Aliment Pharmacol Ther; 2011 Jul; 34(2):214-8. PubMed ID: 21585409
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low clinical relevance of the nonalcoholic fatty liver disease activity score (NAS) in predicting fibrosis progression.
    Ekstedt M; Franzén LE; Mathiesen UL; Kechagias S
    Scand J Gastroenterol; 2012 Jan; 47(1):108-15. PubMed ID: 22126450
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.